[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100619003":3},{"organization":4,"armGroups":7,"interventions":8,"overallOfficials":13,"centralContacts":17,"locations":7,"responsibleParty":22,"collaborators":7,"id":24,"slug":25,"hasResults":26,"nctId":27,"briefTitle":28,"officialTitle":29,"acronym":30,"eligibilityCriteria":31,"healthyVolunteers":26,"sex":32,"minAge":33,"maxAge":7,"enrollmentInfo":34,"targetDuration":7,"studyType":37,"phases":7,"briefSummary":38,"conditions":39,"keywords":42,"overallStatus":45,"whyStopped":7,"lastUpdateSubmitDate":46,"lastUpdatePostDateStruct":47,"startDateStruct":50,"completionDateStruct":52,"leadSponsor":54,"locationsCount":7},{"fullName":5,"class":6},"Aura Biosciences","INDUSTRY",null,[9],{"type":10,"name":11,"description":12,"armGroupLabels":7,"otherNames":7},"OTHER","Observational","The intention is to collect data for an additional \\~5 years (Post AU-011-301 participation)",[14],{"name":15,"affiliation":5,"role":16},"Medical Monitor","STUDY_DIRECTOR",[18],{"name":15,"role":19,"phone":20,"phoneExt":7,"email":21},"CONTACT","617-500-8864","clinical@aurabiosciences.com",{"type":23,"investigatorFullName":7,"investigatorTitle":7,"investigatorAffiliation":7,"oldNameTitle":7,"oldOrganization":7},"SPONSOR","100619003","a-long-term-follow-up-study-of-subjects-completing-the-au-011-301compass-for-early-choroidal-melanoma-100619003",false,"NCT07338968","A Long-Term Follow-Up Study of Subjects Completing the AU-011-301(CoMpass) for Early Choroidal Melanoma","A Long-Term Follow-Up Study of Subjects Completing the AU-011-301 (CoMpass) Trial of Bel-sar for Early Choroidal Melanoma (Indeterminate Lesions\u002FSmall Choroidal Melanomas)","CoMpass","Inclusion Criteria:\n\n* Have received bel-sar or sham treatment in the Aura-sponsored clinical trial AU-011-301.\n* Be willing and able to consent to the AU-011-403 study.\n\nExclusion Criteria:\n\n* None","ALL","18 Years",{"count":35,"type":36},100,"ESTIMATED","OBSERVATIONAL","AU-011-403 is a multicenter long-term follow-up safety and efficacy study of subjects with early CM who previously participated in the AU-011-301 Phase 3 trial. There are no required interventions or use of AU-011 (bel-sar) in this long-term follow-up study",[40,41],"Choroidal Melanoma","Indeterminate Lesions",[43,44],"Ocular Melanoma","Small Choroidal Melanoma","NOT_YET_RECRUITING","2026-01-07",{"date":48,"type":49},"2026-01-14","ACTUAL",{"date":51,"type":36},"2026-02-01",{"date":53,"type":36},"2033-08-15",{"name":5,"class":6}]